Tri-GalNAc(OAc)3 TFA

Tri-GalNAc(OAc)3 TFA is a chemically modified derivative of N-acetylgalactosamine (GalNAc), featuring a trivalent GalNAc scaffold with acetylated hydroxyl groups and supplied as a trifluoroacetic acid salt. As a synthetic carbohydrate conjugate, it is engineered to exploit the high-affinity recognition of GalNAc residues by asialoglycoprotein receptors (ASGPR) predominantly expressed on hepatocyte surfaces. The acetylation of the hydroxyl groups improves compound stability and handling properties, while the trivalent structure enhances receptor binding avidity. Tri-GalNAc(OAc)3 TFA is increasingly relevant in glycobiology, targeted delivery research, and the development of precision biochemical tools, owing to its ability to mediate specific interactions with hepatic cell-surface lectins.

Targeted Delivery System Development: Triantennary GalNAc ligands such as this compound are widely utilized in the design and optimization of targeted delivery platforms for nucleic acids, peptides, and small molecules to hepatocytes. The multivalent presentation of GalNAc units significantly increases binding affinity to ASGPR, enabling selective uptake by liver cells. Researchers employ this molecule to functionalize oligonucleotides or therapeutic payloads, facilitating receptor-mediated endocytosis and enhancing hepatic specificity in preclinical delivery studies.

Glycoconjugate Synthesis: As a versatile glycosylation reagent, the acetylated tri-GalNAc scaffold serves as a key intermediate in the synthesis of diverse glycoconjugates. Its protected form allows for efficient coupling to biomolecules, nanoparticles, or synthetic polymers under mild conditions, supporting the creation of well-defined GalNAc-decorated constructs. These conjugates are instrumental in probing glycan-receptor interactions, mapping carbohydrate recognition motifs, and developing targeted research probes.

Cellular Uptake Mechanism Studies: The compound is frequently used in mechanistic studies to elucidate the pathways and kinetics of ASGPR-mediated endocytosis in hepatocyte models. By conjugating this ligand to fluorescent labels or tracers, researchers can quantitatively assess receptor binding, internalization rates, and intracellular trafficking. Such investigations contribute to a deeper understanding of liver-specific uptake mechanisms and inform the rational design of targeted delivery systems.

Receptor Binding Affinity Assays: Tri-GalNAc(OAc)3 TFA is employed as a standard ligand in in vitro binding assays to characterize the specificity and affinity of ASGPR interactions. It serves as a benchmark for evaluating new GalNAc-based ligands or competitive inhibitors, allowing for the quantitative comparison of binding parameters. These assays are critical in the screening and optimization of ligands intended for hepatocyte targeting in research applications.

Biochemical Tool Development: The unique structural features and receptor selectivity of this trivalent GalNAc derivative make it an essential component in the development of biochemical tools for liver-targeted research. It is used to construct affinity matrices, biosensors, or surface-modified materials that selectively capture or detect ASGPR-expressing cells and proteins. Such tools enable advanced studies in hepatic biology, biomarker discovery, and the evaluation of liver-selective processes in vitro.

1. Implications of ligand-receptor binding kinetics on GLP-1R signalling

2. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

3. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

4. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

5. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes